Business

Green Rain Energy (OTCID: GREH) Announces Review of Legacy Convertible Notes and Strengthened Shareholder Protections

BEVERLY HILLS, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- (“Green Rain Energy” or the “Company”) today announced that, following recently filed Form 8-K disclosures, the Company has initiated a comprehensive review of certain legacy convertible debt instruments issued under predecessor management. The review is being conducted under the guidance of the Company’s accounting advisors and legal counsel to ensure compliance with applicable accounting standards, corporate governance requirements, and

articleMedican Enterprises IncMarch 13, 20264/company/medican-enterprises/news/green-rain-energy-otcid-greh-announces-review-of-legacy-convertible-notes-and-strengthened-shareholder-protections-476
Green Rain Energy (OTCID: GREH) Announces Review of Legacy Convertible Notes and Strengthened Shareholder Protections

About this update from Medican Enterprises Inc

[{"type":"image","alt":"Green Rain Energy Holdings","displaySize":"","headline":null,"caption":"Green Rain Energy Holdings","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":300,"url":"https://media.zenfs.com/en/globenewswire.com/8824614da6482e307799e47ad228233c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/DNouc4F1h6KGdhetzQ_Rdg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTQyMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/8824614da6482e307799e47ad228233c","width":300,"height":300}},"lazy":false},{"type":"text","content":"BEVERLY HILLS, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- (“Green Rain Energy” or the “Company”) today announced that, following recently filed Form 8-K disclosures, the Company has initiated a comprehensive review of certain legacy convertible debt instruments issued under predecessor management. The review is being conducted under the guidance of the Company’s accounting advisors and legal counsel to ensure compliance with applicable accounting standards, corporate governance requirements, and securities regulations.","length":524,"tagName":"p"},{"type":"text","content":"The review focuses primarily on convertible notes associated with historical transactions, including the 2019 acquisition involving Medican Enterprises Inc., which records indicate may have involved a $20,000,000 convertible promissory note bearing 8% interest issued by prior management.","length":288,"tagName":"p"},{"type":"text","content":"Current management, which assumed control of the Company in late 2024, was not involved in negotiating or approving these legacy transactions. As a result, the Board of Directors has authorized a formal validation process to determine the existence, enforceability, valuation, and accounting treatment of such instruments.","length":322,"tagName":"p"},{"type":"text","content":"Temporary Suspension of Legacy Note Conversions","length":47,"tagName":"p"},{"type":"text","content":"As part of this process, the Company has formally advised its transfer agent and relevant parties that no conversions of these legacy convertible notes will be processed unless and until the holders provide sufficient documentation supporting the validity of the instruments and the underlying transactions.","length":307,"tagName":"p"},{"type":"text","content":"The documentation requested includes, but is not limited to...

More updates from Medican Enterprises Inc

The CompanyCompanyaccounting standardsconvertible debtdocumentationtransactionssecurities regulation